Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures

Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to shrink the budget by more than 20% follows commercial setbacks that have persuaded the biotech to take a “more selective and paced approach” to drug development.